The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Lighthouse Imaging Becomes a Novation-Awarded Supplier, Offering Hospital and Medical Center Members Group Purchasing Power for Endoscope Testing Equipment

December 4, 2012 10:48 am | by The Associated Press | News | Comments

Lighthouse Imaging, LLC, a provider of endoscope image quality test equipment, announces it has become a Novation-awarded Supplier. This agreement offers the 2,500 hospitals within the network of member organizations and affiliates served by Novation market-leading pricing for...

Diabetes: Medtronic wins CE Mark for Sentrino continuous glucose monitor

December 4, 2012 10:25 am | by Mass Device | News | Comments

Medical device company Medtronic receives CE Mark approval for its Sentrino continuous glucose management system, the 1st minimally invasive continuous glucose monitoring system specifically designed for use in hospital critical care units.

Cognoptix Exclusively Licenses Alzheimer’s-Detection Technology from the University of California at San Diego: Color-Coded Markers of Beta Amyloid That Empower Doctors to Diagnose Alzheimer’s and Other Neural Diseases Through the Eyes

December 4, 2012 10:13 am | by The Associated Press | News | Comments

ACTON, Mass.--(BUSINESS WIRE)--Dec 4, 2012--Cognoptix, an emerging medical device company previously known as Neuroptix, announced today that it has exclusively licensed groundbreaking technology from the University of California at San Diego (“UC San Diego”), which Cognoptix has developed into an...


Edwards Lifesciences Forecasts Strong Sales and Earnings Growth in 2013

December 4, 2012 9:00 am | by The Associated Press | News | Comments

Edwards Lifesciences Corporation (NYSE: EW) Projected 13 to 16 Percent Underlying Global Sales Growth U.S. Launch Fuels Expected Global THV Sales of $710 to $790 Million ...

BioTime CEO Dr. Michael West Presents Product Development Update at World Stem Cell Summit 2012

December 4, 2012 9:00 am | by The Associated Press | News | Comments

ALAMEDA, Calif.--(BUSINESS WIRE)--Dec 4, 2012--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, Ph.D. will provide an update today on five products being...

Medical Device Veteran Peter Wehrly Joins NLT SPINE’s Board of Directors

December 4, 2012 9:00 am | by The Associated Press | News | Comments

KFAR SABA, Israel--(BUSINESS WIRE)--Dec 4, 2012--NLT SPINE, a developer of products for Minimally Invasive Spine Surgery (MISS) and percutaneous procedures, announced today that Peter Wehrly has joined the company’s Board of Directors. Didier Toubia, NLT SPINE’s CEO, welcomed Mr. Wehrly, saying,...

Vascular Closure Systems, Inc. Announces the Successful Completion of the First in Human (FIH) Clinical Trial of the 6 Fr. / 7 Fr. FastSeal® Bioabsorbable Vascular Access Closure System

December 4, 2012 9:00 am | by The Associated Press | News | Comments

PALO ALTO, Calif.--(BUSINESS WIRE)--Dec 4, 2012--Vascular Closure Systems, Inc.: The Company is pleased to announce the successful conclusion of Phase I and Phase II of the First in Human (FIH) clinical trial for our 6 Fr. / 7 Fr. FastSeal® Bioabsorbable Vascular Access Closure System, achieving...

Covidien Introduces New Surgical Device for Meniscal Repair

December 4, 2012 7:01 am | by The Associated Press | News | Comments

NEW HAVEN, Conn.--(BUSINESS WIRE)--Dec 4, 2012--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the AS Meniscal™ Repair Device. The newest addition to the Company’s line of sports surgery devices, the AS Meniscal Repair Device enables...


Sernova's Novel Method Evaluates Islets Prior to Transplantation and Predicts Their Ability to Reverse Diabetes Post Transplantation

December 4, 2012 6:03 am | by The Associated Press | News | Comments

Sernova Corp. ("Sernova" or the "Company") (TSX VENTURE: SVA) today announced the publication of a novel, sensitive and rapid method developed at Sernova to evaluate insulin-producing donor islets prior to transplant as a predictor of which transplants are most likely to reverse diabetes....

Suntron Corporation Increases Placement and Inspection Capabilities for Miniaturized Medical Devices

December 4, 2012 5:03 am | by The Associated Press | News | Comments

With medical device OEMs requiring smaller, lighter, and longer lasting devices, Suntron Corporation, a leader in integrated electronics manufacturing systems (EMS) and embedded computing solutions, announces that it has the capability to place and inspect the tiny packages needed for...

InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting

December 4, 2012 5:02 am | by The Associated Press | News | Comments

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuardT Embolic Protection Stent (EPS), will sponsor a satellite symposium on December 4th at the ICI, Innovations in Cardiovascular Innovation, Meeting at the David Intercontinental Hotel, Tel-Aviv. ...

Sorin Group Receives PMDA Approval and Announces Commercial Launch of the Mitroflow® Aortic Pericardial Heart Valve in Japan

December 4, 2012 3:35 am | by The Associated Press | News | Comments

MILAN, Italy--(BUSINESS WIRE)--Dec 4, 2012--Sorin Group, (Reuters Code: SORN.MI) a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the Mitroflow ® Aortic...

Elbit Imaging Ltd. Announces InSightec's ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain

December 4, 2012 3:13 am | by Bio-Medicine.Org | News | Comments

TEL AVIV, Israel, December 4, 2012 /- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF ) announced today that on December 3, 2012, Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M) (in which the Company holds approximately 90%), announced that InSightec Ltd. ("InSightec") (in which Elbit Medical holds approximately 64%, and 52.15% on a fully diluted...

CDRH 2013 Strategic Priorities

December 4, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

CDRH's 2013 Strategic Priorities continue and expand upon the work we first started three years ago to reset the direction of the Center towards smart regulation - protecting public health by assuring that devices that enter and remain on the market...

Decision Resources makes it count, buys Abacus

December 4, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Burlington-based health analytics and research firm Decision Resources Group has made its first purchase of an international company with the acquisition of Abacus, a U.K. health economics consultant founded in 1995, the company said Tuesday. Financial details were not disclosed.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.